SKILLMAN, N.J., Feb. 25, 2011 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced a new appointment to its Executive Committee.
Adrienne McNally has been appointed Senior Vice President and Chief Quality Officer for ConvaTec and in this new role, will serve as a member of the ConvaTec Executive Committee. McNally will be responsible for oversight of Global Quality, Regulatory and Medical functions for ConvaTec. McNally, who has been with the company for 22 years, has held positions of increasing responsibility in the R&D, Regulatory, Quality and Environmental, Health & Safety functions.
McNally will fill a vacancy left on the company's Executive Committee with the departure of Dr. Marcus Schabacker, Senior Vice President, Global Science and Innovation and Chief Scientific Officer.
"I am pleased to welcome Adrienne to her new position," stated David Johnson, CEO, ConvaTec. "Her strong leadership and sound business sense will bring tremendous value to the organization and to our Executive Committee."
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.